IMTX:NASDAQ
Immatics NV
၈.၆၂ US$
arrow_downward
-၂.၂၇%(-၀.၂၀) 1D
၈.၅၀ US$
arrow_downward
-၁.၃၉% (-၀.၁၂)bedtimeAfter hours
Closed: စက် ၁၈, GMT-၄ ၁၆:၀၀:၀၀ · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IMTX...
Open
၈.၇၆ US$
High
၈.၈၆ US$
Low
၈.၄၈ US$
Mkt. cap
၁၃၁.၂၂ ဋေ
Avg. vol.
၅.၆၈ သိန်း
Volume
၇.၆၀ သိန်း
52-wk high
၁၂.၄၀ US$
52-wk low
၆.၄၈ US$
EPS
-၁.၈၂ US$
Beta
၁.၃၃
Shares outstanding
၁၄.၉၆ ကုဋေ
No. of employees
၇၀၄
Open
၈.၇၆ US$
High
၈.၈၆ US$
Low
၈.၄၈ US$
Mkt. cap
၁၃၁.၂၂ ဋေ
Avg. vol.
၅.၆၈ သိန်း
Volume
၇.၆၀ သိန်း
52-wk high
၁၂.၄၀ US$
52-wk low
၆.၄၈ US$
EPS
-၁.၈၂ US$
Beta
၁.၃၃
Shares outstanding
၁၄.၉၆ ကုဋေ
No. of employees
၇၀၄
News stories
From web sources and news partners
CarePlus VietNam
·
ပြီးခဲ့သည့် ၃ ပတ်
IMTX Q2 2026 Earnings: Wider-Than-Expected Loss Reflects Ongoing Clinical Investment - Earnings Miss Streak
CarePlus VietNam
·
ပြီးခဲ့သည့် ၁ လ
Immatics (IMTX) Slides 2.01% as Shares Approach Key $8.79 Support Level - Synthetic Short
CarePlus VietNam
·
ပြီးခဲ့သည့် ၁ လ
IMTX Q1 2026 Earnings: Wider-than-Expected Loss Reflects R&D-Driven Burn - EPS Growth Rate
CarePlus VietNam
·
ပြီးခဲ့သည့် ၂ လ
Immatics N.V. (IMTX) Q1 2026 Earnings: EPS Miss Widens as Pre-Revenue Biotech Navigates Clinical Pipeline Costs - Interim Report
About Immatics NV